MedPath

Augmented effect of dry needling and instrument assisted soft tissue mobilization on pain and function in patellofemoral pain syndrome: A randomized Controlled trial

Not Applicable
Conditions
Musculoskeletal Diseases
Registration Number
PACTR202206524864970
Lead Sponsor
Mary Kamal Nassif Takla
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

One hundred participants with LET with age ranging from 15 to 25 years of age and at least one active-MTrPs in the quadriceps femoris will be simply and randomly allocated into four groups—the DDDN; the IASTM; the DDDN and IASTM and the control group. Participants who will meet the following criteria will be selected for this study:
(1) pain during eccentric step test, patellar apprehension test or VM coordination test
(2) pain for more than 6 weeks during at least two of the following activities of walking, squatting, prolonged sitting, stair climbing, isometric quadriceps contraction and patellar compression
(3) the presence of at least one active MTrP in the VMO of the symptomatic knee
(4) Kujala questionnaire score between 40 and 70.

Exclusion Criteria

1- history of ligamentous insufficiency of the knee, meniscal damage, patellar subluxation or dislocation
2- spinal or lower extremity surgery
3- any systemic, orthopaedic or neurological disorder
4- recent physiotherapy programme;
were excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure will be pressure pain threshold (PPT) over the MTrPs. The transducer probe will be placed perpendicular over the MTrP, and pressure will be exerted by pressing the transducer firmly downward. Participants will instructed to say ‘STOP’ when the sensation first change from pressure to pain. The digital display will give the actual pressure applied at the site in kilogram-force representing the PPT value. The examiner will record three consecutive measurements of PPT levels at intervals. of 20 s, and the mean will be considered in the analysis.
Secondary Outcome Measures
NameTimeMethod
Secondary outcome measure will include the anterior knee pain (Kujala) questionnaire. The Kujala questionnaire is a self-administered scale<br>designed to evaluate functionality in patients with PFPS. The Kujala AKPS is a 13-item screening instrument designed to assess patellofemoral pain in adolescents and young adults, with a variable ordinal response format. For example, a 'Limp' score would be scored as follows: none (5), slight/periodic (3), constant (0). The score ranges from a minimum of 0 to a maximum of 100, with higher scores indicating less pain and disability.<br>
© Copyright 2025. All Rights Reserved by MedPath